跳转到主要内容
搜索

晚期临床

注册

最新资源

精选资源

Upcoming late clinical webinars

网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 3 月 17 日 – 10-11 AM ET/CET/JST
网络研讨会

Simcyp® Simulator Version 25: Streamline Drug Development with Regulatory-Compliant PBPK

2026 年 3 月 19 日 - 9:00-10:00am 北京时间
网络研讨会

Building Trust in Data – Transparency, Traceability, and the Human Element

2026 年 3 月 26 日 – APAC 11:00-11:45am IST, EMEA 9:00-9:45am GMT, Americas 2:00-2:45pm ET

Latest late clinical blogs

在以下活动中与我们的专家会面

会议

ACDM 2026

2026 年 3 月 15 - 17 日 - 德国柏林 - Booth 13
会议

SOT Annual Meeting and ToxExpo 2026

March 22 - 25, 2026 – San Diego, CA – Booth 2024
现场活动

Certara IQ™ Global Roadshow

Certara IQ™ is going on the road. From APAC to Europe to North America, our experts are bringing hands-on, indepth

All late clinical resources

FDA Support Drives Shift Toward Bayesian Trial Design

Certara Services, Press Coverage, Video

Single Pivotal Trials Demand Stronger Data and Risk Strategies

Certara Services, Press Coverage

Discovery & Development Europe 2026

Certara Products, Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Certara Services, Clinical Pharmacology, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Advancing Bayesian Methods in Clinical Trials

Certara Services, Press Coverage, Video

Building Trust in Data – Transparency, Traceability, and the Human Element

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Webinar

Understanding and Calculating Steady State Pharmacokinetics

Certara 产品 - Phoenix，建模和模拟 - PK/PD，博客，知识库

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

How does Pinnacle 21 Enterprise differ from the Community version?

Certara Products - Pinnacle 21, Blog

Marbach DDI Workshop 2026

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Modeling and Simulation - PBPK, Conference

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Rare and Neglected Diseases, Blog

Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, On-Demand Webinar
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software